Congenital Adrenal Hyperplasia Clinical Trials

10 recruiting

Congenital Adrenal Hyperplasia Trials at a Glance

13 actively recruiting trials for congenital adrenal hyperplasia are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Córdoba, Ann Arbor, and Angers. Lead sponsors running congenital adrenal hyperplasia studies include Crinetics Pharmaceuticals Inc., IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Federico II University.

Browse congenital adrenal hyperplasia trials by phase

Treatments under study

About Congenital Adrenal Hyperplasia Clinical Trials

Looking for clinical trials for Congenital Adrenal Hyperplasia? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Congenital Adrenal Hyperplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Congenital Adrenal Hyperplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 3

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.150 enrolled26 locationsNCT07144163
Recruiting
Phase 2Phase 3

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.153 enrolled32 locationsNCT07159841
Recruiting

Natural History Study of Patients With Excess Androgen

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,000 enrolled2 locationsNCT00250159
Recruiting
Phase 2

Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old

Congenital Adrenal Hyperplasia
Neurocrine Biosciences6 enrolled3 locationsNCT07187375
Recruiting

Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

Congenital Adrenal Hyperplasia (CAH)Neonatal Salt Loss
IRCCS Azienda Ospedaliero-Universitaria di Bologna25 enrolled1 locationNCT07473804
Recruiting
Phase 1Phase 2

A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia
H. Lundbeck A/S42 enrolled17 locationsNCT05669950
Recruiting

Institutional Registry of Rare Diseases

ParagangliomaPheochromocytomaAmyloidosis+23 more
Hospital Italiano de Buenos Aires380 enrolled1 locationNCT06573723
Recruiting
Phase 2

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.150 enrolled9 locationsNCT06712823
Recruiting
Phase 4

Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

Congenital Adrenal Hyperplasia
Federico II University150 enrolled1 locationNCT03760835
Recruiting

Fertility And Sexual Function In CAH: CALLIOPE

Congenital Adrenal Hyperplasia (CAH)
University of Roma La Sapienza50 enrolled1 locationNCT07099456
Recruiting

Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

Congenital Adrenal Hyperplasia
IRCCS Azienda Ospedaliero-Universitaria di Bologna30 enrolled1 locationNCT06754423
Recruiting

GROWing Up With Rare GENEtic Syndromes

Congenital Adrenal HyperplasiaPrader-Willi SyndromeTuberous Sclerosis+12 more
dr. Laura C. G. de Graaff-Herder600 enrolled1 locationNCT04463316
Recruiting

China Adrenal Disease Registry

PheochromocytomaCongenital Adrenal HyperplasiaCushing Syndrome+5 more
Shanghai Jiao Tong University School of Medicine2,000 enrolled1 locationNCT04890444